KR20150100960A - 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 - Google Patents

골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 Download PDF

Info

Publication number
KR20150100960A
KR20150100960A KR1020157022508A KR20157022508A KR20150100960A KR 20150100960 A KR20150100960 A KR 20150100960A KR 1020157022508 A KR1020157022508 A KR 1020157022508A KR 20157022508 A KR20157022508 A KR 20157022508A KR 20150100960 A KR20150100960 A KR 20150100960A
Authority
KR
South Korea
Prior art keywords
calcium
magnesium
composition
zinc
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157022508A
Other languages
English (en)
Korean (ko)
Inventor
윤 카우 탐
저 린
Original Assignee
뷰티 펄 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뷰티 펄 그룹 리미티드 filed Critical 뷰티 펄 그룹 리미티드
Publication of KR20150100960A publication Critical patent/KR20150100960A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pediatric Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020157022508A 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 Ceased KR20150100960A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2399708P 2008-01-28 2008-01-28
US61/023,997 2008-01-28
PCT/IB2009/005042 WO2009095798A2 (en) 2008-01-28 2009-01-28 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020107015770A Division KR101577083B1 (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Publications (1)

Publication Number Publication Date
KR20150100960A true KR20150100960A (ko) 2015-09-02

Family

ID=40913349

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020157022508A Ceased KR20150100960A (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
KR1020107015770A Active KR101577083B1 (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020107015770A Active KR101577083B1 (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Country Status (9)

Country Link
US (4) US9308222B2 (enExample)
EP (2) EP2257300B1 (enExample)
JP (2) JP5419298B2 (enExample)
KR (2) KR20150100960A (enExample)
CN (2) CN101925357B (enExample)
AU (1) AU2010212456B2 (enExample)
CA (1) CA2712647C (enExample)
NZ (1) NZ585408A (enExample)
WO (1) WO2009095798A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150100960A (ko) * 2008-01-28 2015-09-02 뷰티 펄 그룹 리미티드 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
IT1400231B1 (it) * 2010-05-07 2013-05-24 Pharmanutra S R L Effetti dell' associazione di vitamina k2 e vitamina d3 nel consolidamento di una frattura ossea.
ITMI20110771A1 (it) * 2011-05-06 2012-11-07 Pharmanutra S R L Composizione comprendente una associazione di vitamine per uso nel trattamento della algodistrofia.
CA2816207C (en) * 2011-07-27 2014-11-18 Sinoveda Canada, Inc. Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
CN103796658A (zh) * 2011-07-28 2014-05-14 加拿大生维达有限公司 含有高溶性元素和维生素并能预防和改善骨质疏松症的组合物
CN103416684A (zh) * 2013-08-05 2013-12-04 买世禄 改善骨质增生和关节疼痛的氨基酸结合多种微量元素的保健食品的生产方法
US20200397818A1 (en) * 2017-07-31 2020-12-24 Avalon Bone Supplement (Hk) Limited Multi-Mineral Supplement for Improved Bone Density
KR102230498B1 (ko) 2019-07-31 2021-03-22 보비씨엔이(주) 골다공증 치료용 수소흡장 칼슘 함유 조성물
KR102920552B1 (ko) 2024-01-03 2026-01-30 김도영 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075499A (en) 1988-11-21 1991-12-24 Board Of Regents, The University Of Texas System Calcium supplementation by dicalcium citrate-lactate
CN1027419C (zh) 1990-08-08 1995-01-18 李久成 醋酸钙的制备方法及用途
TW383223B (en) 1992-07-13 2000-03-01 Shiseido Co Ltd External skin treatment composition
CN1082836A (zh) * 1993-04-07 1994-03-02 苑德仲 制取钙质食品强化剂的方法
CN1039196C (zh) * 1993-05-28 1998-07-22 李晓焰 从珍珠、贝壳、珊瑚中提取保健钙剂的方法
US6716454B2 (en) 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
IL115241A (en) 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
JP3438447B2 (ja) * 1994-12-28 2003-08-18 セイコーエプソン株式会社 テープ状記録媒体の印刷装置および印刷方法並びにテープ状記録媒体
US5698222A (en) 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
JPH1014535A (ja) 1996-07-05 1998-01-20 Karunaa:Kk 飲食品用カルシウム剤
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6447809B1 (en) 1999-05-11 2002-09-10 Metagenics, Inc. Composition for promoting healthy bone structure
CN1117561C (zh) 1999-07-26 2003-08-13 李久成 复合钙制剂及其制备方法和用途
US6790462B2 (en) 2001-08-09 2004-09-14 Rhodia Inc. Calcium dietary supplement
US6881419B2 (en) * 2002-04-09 2005-04-19 William E. Lovett Vitamin formulation for enhancing bone strength
US20050215493A1 (en) 2002-05-01 2005-09-29 Masaki Miyake Calcium-containing tissue strengthening agents and use thereof
CN1221268C (zh) 2002-10-11 2005-10-05 兰为民 镁钙离子复合制剂及其生产工艺
US8703209B2 (en) 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
TW200640479A (en) 2005-05-30 2006-12-01 Pin-Hong Li Composition of Chinese medicine
TW200711648A (en) 2005-09-22 2007-04-01 Ching-Shun Wu Vitamins, minerals and regiment of plants for autonomic nervous system (including the vagus nerve) disorder or obstacle
CA2633868A1 (en) * 2005-12-20 2007-07-05 Alcon Research, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
JP2008013469A (ja) 2006-07-05 2008-01-24 Takeshi Ogura 海洋ミネラル成分からなる骨粗鬆症治療および／または予防剤
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
KR20150100960A (ko) 2008-01-28 2015-09-02 뷰티 펄 그룹 리미티드 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
TWI516279B (zh) 2010-07-28 2016-01-11 布爾頓國際集團有限公司 預防和改善骨質疏鬆症之含有高可溶性元素及維生素的調配物
CA2816207C (en) 2011-07-27 2014-11-18 Sinoveda Canada, Inc. Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis

Also Published As

Publication number Publication date
JP5419298B2 (ja) 2014-02-19
EP2257300A2 (en) 2010-12-08
KR20100107468A (ko) 2010-10-05
KR101577083B1 (ko) 2015-12-11
US9308222B2 (en) 2016-04-12
AU2010212456A1 (en) 2010-09-09
CN102908623A (zh) 2013-02-06
US20140342018A1 (en) 2014-11-20
CN101925357B (zh) 2012-12-12
CA2712647C (en) 2016-08-30
US20110312923A1 (en) 2011-12-22
JP2011510922A (ja) 2011-04-07
EP2257300B1 (en) 2014-08-27
US20100292194A1 (en) 2010-11-18
HK1149206A1 (en) 2011-09-30
US20140154332A1 (en) 2014-06-05
CA2712647A1 (en) 2009-08-06
NZ585408A (en) 2012-06-29
WO2009095798A2 (en) 2009-08-06
WO2009095798A3 (en) 2009-10-15
JP2014076995A (ja) 2014-05-01
EP2815751A1 (en) 2014-12-24
AU2010212456B2 (en) 2013-08-22
CN101925357A (zh) 2010-12-22
EP2257300A4 (en) 2012-04-18

Similar Documents

Publication Publication Date Title
KR101577083B1 (ko) 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
Younes et al. Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats
US5128374A (en) Use of calcium citrate malate for the treatment of osteoporosis and related disorders
EP0304986B1 (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
Zhao et al. Acute versus chronic effects of whey proteins on calcium absorption in growing rats
AU2012288401B2 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
JP2005522485A (ja) 石灰化された動脈プラークの蓄積および細胞の機能不全を軽減し、イオンカルシウムの釣合いをとるための方法
KIKUNAGA et al. The bioavailability of magnesium in spinach and the effect of oxalic acid on magnesium utilization examined in diets of magnesium-deficient rats
CN103796658A (zh) 含有高溶性元素和维生素并能预防和改善骨质疏松症的组合物
HK1149206B (en) Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
JP2006213627A (ja) 骨粗鬆症発症予防剤
KR20170068147A (ko) 어린이의 골력과 치아의 발달을 보조하도록 구성되는 멸치 칼슘과 마그네슘, 아연 및 비타민d3를 포함하는 과립조성물
Khokhar et al. 19 Micronutrients
Kalro et al. Calcium Requirements and Sources in Postmenopausal Women
Brady et al. OsteoForce™
CN103417520A (zh) 组合钙制剂
KR20050011987A (ko) 늙은 호박을 함유한 발효유 조성물

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150820

Application number text: 1020107015770

Filing date: 20100716

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150921

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151119

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160609

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151119

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I